LPL Financial
AMPE

LPL Financial’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

LPL Financial’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$4K – 4651
2022
Q3 		$4K Sell
200
-72
-26% -$2.52K ﹤0.01% 4404
2022
Q2 		$14K Buy
272
+5
+2% +$372 ﹤0.01% 4370
2022
Q1 		$38K Buy
267
+22
+9% +$3.21K ﹤0.01% 4079
2021
Q4 		$42K Sell
245
-82
-25% -$30.6K ﹤0.01% 4250
2021
Q3 		$163K Sell
327
-35
-10% -$16.2K ﹤0.01% 4043
2021
Q2 		$181K Buy
362
+153
+73% +$82.2K ﹤0.01% 3932
2021
Q1 		$106K Sell
209
-18
-8% -$9.28K ﹤0.01% 3917
2020
Q4 		$108K Sell
227
-44
-16% -$14.4K ﹤0.01% 3671
2020
Q3 		$78K Buy
271
+16
+6% +$3.97K ﹤0.01% 3404
2020
Q2 		$49K Sell
255
-80
-24% -$13.3K ﹤0.01% 3352
2020
Q1 		$42K Buy
335
+32
+11% +$5.79K ﹤0.01% 3098
2019
Q4 		$53K Hold
303
– – ﹤0.01% 3272
2019
Q3 		$45K Buy
303
+8
+3% +$1.07K ﹤0.01% 3215
2019
Q2 		$34K Buy
+295
New +$46.7K ﹤0.01% 3221
2018
Q3 		– Sell
-100
Closed -$66K – 3333
2018
Q2 		$66K Hold
100
– – ﹤0.01% 3134
2018
Q1 		$102K Buy
100
+6
+6% +$5.02K ﹤0.01% 3074
2017
Q4 		$115K Buy
+94
New +$44.2K ﹤0.01% 2917
2017
Q3 		– Sell
-34
Closed -$5K – 2957
2017
Q2 		$5K Hold
34
– – ﹤0.01% 2793
2017
Q1 		$8K Hold
34
– – ﹤0.01% 2694
2016
Q4 		$10K Hold
34
– – ﹤0.01% 2670
2016
Q3 		$8K Hold
34
– – ﹤0.01% 2622
2016
Q2 		$12K Sell
34
-34
-50% -$37.1K ﹤0.01% 2601
2016
Q1 		$55K Sell
68
-5
-7% -$3.37K ﹤0.01% 2995
2015
Q4 		$69K Buy
73
+15
+26% +$14.8K ﹤0.01% 3022
2015
Q3 		$51K Sell
58
-7
-11% -$5.86K ﹤0.01% 2715
2015
Q2 		$47K Buy
65
+17
+35% +$18.1K ﹤0.01% 2808
2015
Q1 		$108K Buy
48
+13
+37% +$22.2K ﹤0.01% 2669
2014
Q4 		$36K Sell
35
-18
-34% -$19.2K ﹤0.01% 2675
2014
Q3 		$56K Buy
53
+4
+8% +$6.74K ﹤0.01% 2638
2014
Q2 		$122K Buy
49
+4
+9% +$8.16K ﹤0.01% 2580
2014
Q1 		$86K Sell
45
-248
-85% -$586K ﹤0.01% 2563
2013
Q4 		$626K Buy
293
+65
+29% +$154K ﹤0.01% 1576
2013
Q3 		$528K Hold
228
– – ﹤0.01% 1613
2013
Q2 		$394K Buy
+228
New +$362K ﹤0.01% 1723

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

LPL Financial's AMPE Position: Q4 2022 in Review

LPL Financial sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 200 shares — an estimated $4K sold.

LPL Financial first reported a position in AMPE in Q2 2013 and held it in 34 quarters. The position peaked at $626K in Q4 2013. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • LPL Financial reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • LPL Financial sold 200 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $4K.
  • LPL Financial first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 34 quarters.
  • LPL Financial's Ampio Pharmaceuticals Inc. position peaked at $626K in Q4 2013.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.